S

Stuart L. Schreiber

Broad Institute

ORCID: 0000-0003-1922-7558

Publishes on Chemical Synthesis and Analysis, Melanoma and MAPK Pathways, Computational Drug Discovery Methods. 1.3k papers and 134.1k citations.

PubIndex Score98Top 2%How it's scored

🌟#3 Current Senior Leader in Histone Deacetylase Inhibitors Research 🌟#3 Current Senior Leader in Signaling Pathways in Disease 🌟#5 Current Senior Leader in Cancer, Lipids, and Metabolism 🌟#5 Current Senior Leader in Piperaceae Chemical and Biological Studies 🌟#9 Current Senior Leader in Advanced Biosensing Techniques and Applications

1.3kPublications

134.1kTotal Citations

#3in Histone Deacetylase Inhibitors Research

First publication: 1978First senior author: 1987

Chemical Synthesis and Analysis Melanoma and MAPK Pathways Computational Drug Discovery Methods Synthetic Organic Chemistry Methods Signaling Pathways in Disease

Top publicationsby citations

Regulation of Ferroptotic Cancer Cell Death by GPX4

Wan Seok Yang, Brent R. Stockwell, Rohitha Sriramaratnam et al.|Cell|2014

Cited by 7.5k

A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells

B Bernstein, Eric S. Lander, Tarjei S. Mikkelsen et al.|Cell|2006

Cited by 5.4k

Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway

Vasanthi S. Viswanathan, Stuart L. Schreiber, Matthew J. Ryan et al.|Nature|2017

Cited by 2k

A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis

Yilong Zou, Stuart L. Schreiber|Nature Communications|2019

Cited by 859

The promise and peril of chemical probes

C.H. Arrowsmith, Michael A. Walters, Saul H. Rosenberg et al.|Nature Chemical Biology|2015

Cited by 848